Comparison of quantitatively analyzed dynamic area-detector CT using various mathematic methods with FDG PET/CT in management of solitary pulmonary nodules

American Journal of Roentgenology

Volumn 200, Issue 6, 2013, Pages

  Ohno, Yoshiharu ^a   Nishio, Mizuho ^a   Koyama, Hisanobu ^a   Fujisawa, Yasuko ^b   Yoshikawa, Takeshi ^a   Matsumoto, Sumiaki ^a   Sugimura, Kazuro ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOSHIBA MEDICAL SYSTEMS CORPORATION   (Japan)

Author keywords

CT; Lung; Nodule; Perfusion; PET CT

Indexed keywords

IOPAMIDOL; CONTRAST MEDIUM; DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

AGED; AREA UNDER THE CURVE; ARTERY PERFUSION; ARTICLE; BACTERIUM EXAMINATION; BLOOD VOLUME; COMPARATIVE STUDY; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGING SOFTWARE; INTERMETHOD COMPARISON; LUNG CANCER; LUNG NODULE; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; MCNEMAR TEST; OXYGEN EXTRACTION FRACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; COMPUTER ASSISTED DIAGNOSIS; METHODOLOGY; MICROBIOLOGY; RADIOGRAPHY; REPRODUCIBILITY; SCINTISCANNING;

AGED; CONTRAST MEDIA; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SOLITARY PULMONARY NODULE; TOMOGRAPHY, X-RAY COMPUTED;

MLCS; MLOWN;

EID: 84880949058     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.12.9197     Document Type: Article

References (33)

1. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999; 354:99-105
2. Swensen SJ, Jett JR, Hartman TE, et al. CT screening for lung cancer: five-year prospective experience. Radiology 2005; 235:259-265
3. National Lung Screening Trial Research Team; Aberle DR, Adams AM, Berg CD, et al. Reduced lungcancer mortality with low-dose computed tomographic screening. N Engl J Med 2011; 365:395-409
4. Swensen SJ, Viggiano RW, Midthun DE, et al. Lung nodule enhancement at CT: multicenter study. Radiology 2000; 214:73-80
5. Ohno Y, Hatabu H, Takenaka D, Adachi S, Kono M, Sugimura K. Solitary pulmonary nodules: potential role of dynamic MR imaging in management-initial experience. Radiology 2002; 224:503-511
6. Schaefer JF, Vollmar J, Schick F, et al. Solitary pulmonary nodules: dynamic contrast-enhanced MR imaging-perfusion differences in malignant and benign lesions. Radiology 2004; 232:544-553
7. Jeong YJ, Lee KS, Jeong SY. Solitary pulmonary nodule: characterization with combined wash-in and wash-out features at dynamic multi-detector row CT. Radiology 2005; 237:675-683
8. Bryant AS, Cerfolio RJ. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules. Ann Thorac Surg 2006; 82:1016-1020
9. Cronin P, Dwamena BA, Kelly AM, Carlos RC. Solitary pulmonary nodules: meta-analytic comparison of cross-sectional imaging modalities for diagnosis of malignancy. Radiology 2008; 246:772-782
10. Ohno Y, Koyama H, Takenaka D, et al. Dynamic MRI, dynamic multidetector-row computed tomography (MDCT), and coregistered 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)/CT: comparative study of capability for management of pulmonary nodules. J Magn Reson Imaging 2008; 27:1284-1295
11. Sitartchouk I, Roberts HC, Pereira AM, Bayanati H, Waddell T, Roberts TP. Computed tomography perfusion using first pass methods for lung nodule characterization. Invest Radiol 2008; 43:349-358
12. Li Y, Yang ZG, Chen TW, Yu JQ, Sun JY, Chen HJ. First-pass perfusion imaging of solitary pulmonary nodules with 64-detector row CT: comparison of perfusion parameters of malignant and benign lesions. Br J Radiol 2010; 83:785-790
13. Ohno Y, Koyama H, Matsumoto K, et al. Differentiation of malignant and benign pulmonary nodules with quantitative first-pass 320-detector row perfusion CT versus FDG PET/CT. Radiology 2011; 258:599-609
14. Milne EN. Circulation of primary and metastatic pulmonary neoplasms: a postmortem microarteriographic study. Am J Roentgenol Radium Ther Nucl Med 1967; 100:603-619
15. Oikawa M, Milne EN, Whitmore E, Gilday D, Oliver C. A morphological and quantitative study of tumor blood flow. Part I. During growth and immune rejection. Cancer 1975; 35:385-398
16. Milne EN. Pulmonary metastases: vascular supply and diagnosis. Int J Radiat Oncol Biol Phys 1976; 1:739-742
17. Milne EN. Pulmonary blood flow distribution. Invest Radiol 1977; 12:479-481
18. Milne EN, Zerhouni EA. Blood supply of pulmonary metastases. J Thorac Imaging 1987; 2:15-23
19. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983; 3:1-7
20. Hoffman EA, Tajik JK, Kugelmass SD. Matching pulmonary structure and perfusion via combined dynamic multislice CT and thin-slice high-resolution CT. Comput Med Imaging Graph 1995; 19:101-112
21. Tsushima Y, Funabasama S, Sanada S, Aoki J, Endo K. Development of perfusion CT software for personal computers. Acad Radiol 2002; 9:922-926
22. Kiessling F, Boese J, Corvinus C, et al. Perfusion CT in patients with advanced bronchial carcinomas: a novel chance for characterization and treatment monitoring? Eur Radiol 2004; 14:1226-1233
23. Ng QS, Goh V, Fichte H, et al. Lung cancer perfusion at multi-detector row CT: reproducibility of whole tumor quantitative measurements. Radiology 2006; 239:547-553
24. Ng QS, Goh V, Milner J, Padhani AR, Saunders MI, Hoskin PJ. Acute tumor vascular effects following fractionated radiotherapy in human lung cancer: in vivo whole tumor assessment using volumetric perfusion computed tomography. Int J Radiat Oncol Biol Phys 2007; 67:417-424
25. Miyazaki S, Murase K, Yoshikawa T, Morimoto S, Ohno Y, Sugimura K. A quantitative method for estimating hepatic blood flow using a dual-in-put single-compartment model. Br J Radiol 2008; 81:790-800
26. Kanda T, Yoshikawa T, Ohno Y, et al. Hepatic computed tomography perfusion: comparison of maximum slope and dual-input single-compartment methods. Jpn J Radiol 2010; 28:714-719
27. Kanda T, Yoshikawa T, Ohno Y, et al. CT hepatic perfusion measurement: comparison of three analytic methods. Eur J Radiol 2012; 81:2075-2079
28. Kanda T, Yoshikawa T, Ohno Y, et al. Perfusion measurement of the whole upper abdomen of patients with and without liver diseases: initial experience with 320-detector row CT. Eur J Radiol 2012; 81:2470-2475
29. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1:307-310
30. Ohno Y, Murase K, Higashino T, et al. Assessment of bolus injection protocol with appropriate concentration for quantitative assessment of pulmonary perfusion by dynamic contrast-enhanced MR imaging. J Magn Reson Imaging 2007; 25:55-65
31. Littleton JT, Durizch ML, Moeller G, Herbert DE. Pulmonary masses: contrast enhancement. Radiology 1990; 177:861-871
32. Cotran RS, Kumar V, Collins T, eds. Acute and chronic inflammation. Robbins pathologic basis of disease, 6th ed. Philadelphia, PA: Saunders, 1999:50-88
33. Levitzky MG, ed. Blood flow to the lung. Pulmonary physiology, 5th ed. New York, NY: McGraw-Hill, 1999:85-111